PHILIP FRICK: Open Payments
NPI 1689627044 · EAST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,319 in 223 payments from 18 companies in 2025. Trend: 2023 $4,119 · 2024 $3,629 · 2025 $4,319
Food & beverage: $4,313Education: $5
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $812 |
| Neurocrine BioSciences, Inc. | 29 | $673 |
| Otsuka America Pharmaceutical, Inc. | 30 | $557 |
| ABBVIE INC. | 27 | $504 |
| Lundbeck LLC | 18 | $365 |
| Axsome Therapeutics, Inc. | 17 | $340 |
| Janssen Pharmaceuticals, Inc | 15 | $249 |
| E.R. Squibb & Sons, L.L.C. | 13 | $206 |
| Teva Pharmaceuticals USA, Inc. | 9 | $161 |
| Vanda Pharmaceuticals Inc. | 13 | $156 |
Products named: CAPLYTA, INGREZZA, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, Auvelity, COBENFY, INVEGA SUSTENNA.
Industry payments across CT — which companies pay providers there.
